Skip to main content
SpringerLink
Log in

Supportive Therapie und Palliativmedizin bei Patienten mit malignen Gliomen

Supportive care and palliation in patients with malignant gliomas

  • Themenschwerpunkt
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Summary

The primary aim of supportive care in patients with malignant gliomas is accurate symptom control in order to optimize quality of life. The palliative approach should be considered from the beginning of treatment, due to the intractable and incurable character of the disease. Neurological signs and symptoms have to be investigated clinically, as well as neuroradiologically in order to evaluate treatment response and to provide adequate supportive care.

Zusammenfassung

Das primäre Ziel der supportiven Therapie bei Patienten mit maligen Gliomen ist eine bestmögliche Symptomkontrolle, um eine optimale Lebensqualität für den Patienten zu gewährleisten. Der palliative Ansatz sollte schon vom Beginn der ersten therapeutischen Maßnahmen zum Tragen kommen, da maligne Gliome trotz verschiedenster Therapiestrategien nur schwer kontrollierbar und in jedem Fall nicht heilbar sind. Neurologische Symptome und Defizite sollten im Verlauf der Erkrankung sowohl klinisch und neuroradiologisch untersucht werden, um einerseits den Effekt gegen den Tumor gerichteter Therapien als auch supportive Maßnahmen evaluieren zu können.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Davies E, Clarke C (2005) Views of bereaved relatives about quality of survival after radiotherapy for malignant cerebral glioma. J Neurol Neurosurg Psychiatry 76: 555–561

    Article  PubMed  CAS  Google Scholar 

  • de Wit MC, de Bruin HG, Eijkenboom W, Sillevis Smitt PA, van den Bent MJ (2004) Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 63: 535–537

    PubMed  CAS  Google Scholar 

  • Laigle F, Martin-Duverneuil N, Carpentier A, Hoang-Xuan K, Delattre JY (2002) Seizure-related contrast enhancement of a ganglioglioma. Neurology 58: 1538

    PubMed  CAS  Google Scholar 

  • Kawahara I, Tsutsumi K, Hirose M, Matsuo Y, Yokoyama H (2004) Transient abnormalities associated with status epilepticus on diffusion-weighted MR imaging. No To Shinkei 56: 333–338

    PubMed  Google Scholar 

  • Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW (1999) MRI abnormalities associated with partial status epilepticus. Neurology 52: 1021–1027

    PubMed  CAS  Google Scholar 

  • Kim JA, Chung JI, Yoon PH, Kim DI, Chung TS, Kim EJ, Jeong EK (2001) Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging. AJNR Am J Neuroradiol 22: 1149–1160

    PubMed  CAS  Google Scholar 

  • Oberndorfer S, Lindeck-Pozza E, Lahrmann L, Struhal W, Hitzenberger H, Grisold W (2006) The "end of life" hospital setting in patients with malignant gliomas. Neurooncol (submitted)

  • Peterson K (2004) Neoplasms. In: Voltz R, Bernat LL et al (eds) Palliative Care in Neurology. Contemporary neurology series. Oxford University Press, Oxford, Chapter 4, pp 37–47

    Google Scholar 

  • Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76: 562–568

    Article  PubMed  CAS  Google Scholar 

  • Massie MJ, Holland JC, Glass E (1989) Overview of normal reaction and praevalence of psychiatric disorder. In: Holland JC, Rowland JH (eds) Handbook of psychooncology. Psychological care of the patient with cancer. Oxford University Press, New York, pp 273–282

    Google Scholar 

  • Cherny NI, Coyle N, Foley KM (1994) Suffering in the advanced cancer patient: a definition and taxonomy. J Palliat Care 10: 57–70

    PubMed  CAS  Google Scholar 

  • Posner JB (1995) Neurological complications in cancer. FA Davis Company, Philadelphia, pp 59–66

    Google Scholar 

  • Hildebrand J, Brada M (2001) Brain oedema. In: Differential Diagnosis in Neuro-oncology. Oxford University Press, New York, pp 47–58

    Google Scholar 

  • Das A, Banik NL, Patel SJ, Ray SK (2004) Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 3: 36

    Article  PubMed  CAS  Google Scholar 

  • Sur P, Sribnick EA, Patel SJ, Ray SK, Banik NL (2005) Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. Glia 50: 160–167

    Article  PubMed  Google Scholar 

  • Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, Roos W, Kaina B, Weller M (2006) O-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem 96(3): 766–776

    Article  PubMed  CAS  Google Scholar 

  • U Schlegel (??) Klinische Symptomatik und allgemeine Terapie. In: Schlegel U, Weller M, Westphal M (Hrsg) Neuroonkologie. Georg Thieme, Stuttgart New York, pp 84–92

  • Oberndorfer S, Schmal T, Lahrmann H, Urbanits S, Lindner K, Grisold W (2002) The frequency of seizures in patients with primary brain tumors or cerebral metastases. Wien Klin Wochenschr 114 (21–22): 911–916

    PubMed  Google Scholar 

  • Cobbs JL, Lekos A, Cole BF, Recht L, Mills PC, Akerley W, Glantz MJ (1997) Natural history of seizures and the role of anticonvulsants in patients with primary and metastatic central nervous system cancer. Neurology 48: A19 (abstract)

    Article  Google Scholar 

  • Oberndorfer S, Piribauer M, Marosi Ch, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72(3): 255–260

    Article  PubMed  CAS  Google Scholar 

  • Forsyth PA, Posner JB (1993) Headaches in patients with brain tumors: a study of 111 patients. Neurology 43: 1678–1683

    PubMed  CAS  Google Scholar 

  • Siraj M Husain, et al (2003) Headache associated with intracranial neoplasms. In: Schiff D, Wen PY (eds) Cancer Neurology in Clinical Practice. Humana Press, Totowa, New Jersey, pp 23–39

    Google Scholar 

  • Pfund Z, Szapary L, Jaszberenyi O, Nagy F, Czopf J (1999) Headache in intracranial tumors. Cephalalgia 19: 787–790; discussion 765

    Article  PubMed  CAS  Google Scholar 

  • Purdy RA, Kirby S (2004) Headaches and brain tumors. Neurol Clin 22: 39–53

    Article  PubMed  Google Scholar 

  • Hess B, Oberndorfer S, Urbanits S, Lahrmann H, Horvath-Mechtler B, Grisold W (2005) Trigeminal neuralgia in two patients with glioblastoma. Headache 45: 1267–1270

    Article  PubMed  Google Scholar 

  • Cummings J (1985) Behavioral disorders associated with frontal lobe injury. In: Clinical neuropsychiatry. Grune Stratton, Orlando, pp 57–74

    Google Scholar 

  • Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55: 992–999

    Article  PubMed  CAS  Google Scholar 

  • Madhusoodanan S, Danan D, Brenner R, Bogunovic O (2004) Brain tumor and psychiatric manifestations: a case report and brief review. Ann Clin Psychiatry 16: 111–113

    PubMed  Google Scholar 

  • Meyers CA, Hess KR, Yung WK, Levin VA (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18: 646–650

    PubMed  CAS  Google Scholar 

  • McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB (1995) Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 52: 89–99

    PubMed  CAS  Google Scholar 

  • Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, Leenstra S et al. (2002) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. Curr Neurol Neurosci Rep 2: 203–204

    Google Scholar 

  • John G, Eapen V, Shaw GK (1997) Frontal glioma presenting as anxiety and obsessions: a case report. Acta Neurol Scand 96: 194–195

    Article  PubMed  CAS  Google Scholar 

  • Moise D, Madhusoodanan S (2006) Psychiatric symptoms associated with brain tumors: a clinical enigma. CNS Spectr 11: 28–31

    PubMed  Google Scholar 

  • Berney A, Stiefel F, Mazzocato C, Buclin T (2000) Psychopharmacology in supportive care of cancer: a review for the clinician. III. Antidepressants. Support Care Cancer 8: 278–286

    PubMed  CAS  Google Scholar 

  • Schmidinger M, Linzmayer L, Becherer A, Fazeny-Doemer B, Fakhrai N, Prayer D, Killer M et al. (2003) Psychometric- and quality-of-life assessment in long-term glioblastoma survivors. J Neurooncol 63: 55–61

    Article  PubMed  Google Scholar 

  • Lovely MP, Miaskowski C, Dodd M (1999) Relationship between fatigue and quality of life in patients with glioblastoma multiforme. Oncol Nurs Forum 26: 921–925

    PubMed  CAS  Google Scholar 

  • Wagner LI, Cella D, Doninger NA (2004) Fatigue. In: Voltz R, Bernat LL et al (eds) Palliative Care in Neurology. Contemporary neurology series. Oxford University Press, Oxford, Chapter 21, pp 221–227

    Google Scholar 

  • Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85: 1186–1196

    Article  PubMed  CAS  Google Scholar 

  • Cheruku R, Tapazoglou E, Ensley J, Kish JA, Cummings GD, al-Sarraf M (1991) The incidence and significance of thromboembolic complications in patients with highgrade gliomas. Cancer 68: 2621–2624

    Article  PubMed  CAS  Google Scholar 

  • Sawaya R, Highsmith RF (1992) Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile. J Neurooncol 14: 113–118

    PubMed  CAS  Google Scholar 

  • Willis BK (1991) Timing of anticoagulant therapy for thromboembolic complications after craniotomy for brain tumors. Neurosurgery 28: 929–930

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Abteilung, Kaiser Franz Josef Spital der Stadt Wien (SMZ-Süd) und Ludwig Boltzmann-Institut für Neuroonkologie, Wien, Austria

    Stefan Oberndorfer & Heinz Lahrmann

Authors
  1. Stefan Oberndorfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Heinz Lahrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Oberndorfer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oberndorfer, S., Lahrmann, H. Supportive Therapie und Palliativmedizin bei Patienten mit malignen Gliomen. Wien Med Wochenschr 156, 364–368 (2006). https://doi.org/10.1007/s10354-006-0309-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-006-0309-2

Keywords

Schlüsselwörter

Search

Navigation